Stocks and Investing Stocks and Investing
Mon, February 26, 2024
[ 12:00 AM ] - United States, WOPRAI
Blair Abernethy Upgraded (BSY) to Strong Buy and Increased Target to $60 on, Feb 26th, 2024
[ 12:00 AM ] - United States, WOPRAI
Brian Essex Maintained (ZS) at Hold with Increased Target to $240 on, Feb 26th, 2024
[ 12:00 AM ] - United States, WOPRAI
Hamza Fodderwala Maintained (ZS) at Hold with Increased Target to $214 on, Feb 26th, 2024
[ 12:00 AM ] - United States, WOPRAI
Mathieu Robilliard Maintained (VIV) at Hold with Increased Target to $14 on, Feb 26th, 2024
[ 12:00 AM ] - United States, WOPRAI
Connor Siversky Downgraded (VTR) to Hold and Held Target at $46 on, Feb 26th, 2024
[ 12:00 AM ] - United States, WOPRAI
Matt Miksic Maintained (BLCO) at Hold with Increased Target to $18 on, Feb 26th, 2024
[ 12:00 AM ] - United States, WOPRAI
Matthew Bouley Maintained (BLDR) at Buy with Increased Target to $235 on, Feb 26th, 2024
[ 12:00 AM ] - United States, WOPRAI
Shyam Patil Maintained (BKNG) at Buy on, Feb 26th, 2024
[ 12:00 AM ] - United States, WOPRAI
Nicholas Jones Maintained (BKNG) at Buy on, Feb 26th, 2024
[ 12:00 AM ] - United States, WOPRAI
Jeffrey Bernstein Maintained (BLMN) at Buy with Increased Target to $32 on, Feb 26th, 2024
[ 12:00 AM ] - United States, WOPRAI
Andrew Strelzik Maintained (BLMN) at Hold with Increased Target to $29 on, Feb 26th, 2024
[ 12:00 AM ] - United States, WOPRAI
Arun Viswanathan Maintained (WLK) at Hold with Decreased Target to $134 on, Feb 26th, 2024
[ 12:00 AM ] - United States, WOPRAI
Simeon Gutman Maintained (WMT) at Buy with Decreased Target to $67 on, Feb 26th, 2024
[ 12:00 AM ] - United States, WOPRAI
Rupesh Parikh Maintained (WMT) at Buy with Decreased Target to $67 on, Feb 26th, 2024
[ 12:00 AM ] - United States, WOPRAI
Philip Cusick Maintained (WBD) at Hold with Decreased Target to $10 on, Feb 26th, 2024
[ 12:00 AM ] - United States, WOPRAI
Benjamin Swinburne Maintained (WBD) at Hold with Decreased Target to $10 on, Feb 26th, 2024
[ 12:00 AM ] - United States, WOPRAI
James Goss Maintained (WBD) at Buy with Decreased Target to $16 on, Feb 26th, 2024
[ 12:00 AM ] - United States, WOPRAI
Barton Crockett Maintained (WBD) at Strong Sell with Decreased Target to $7 on, Feb 26th, 2024
[ 12:00 AM ] - United States, WOPRAI
Michael Cherny Initiated (WBA) at Hold and Held Target at $23 on, Feb 26th, 2024
[ 12:00 AM ] - United States, WOPRAI
Brent Bracelin Reiterated (WDAY) at Buy and Held Target at $330 on, Feb 26th, 2024
[ 12:00 AM ] - United States, WOPRAI
Alexander Sklar Upgraded (WEAV) to Strong Buy and Held Target at $15 on, Feb 26th, 2024
Fri, February 23, 2024
[ 12:00 AM ] - United States, WOPRAI
Selman Akyol Maintained (WES) at Strong Buy with Increased Target to $36 on, Feb 23rd, 2024
[ 12:00 AM ] - United States, WOPRAI
Youssef Squali Maintained (W) at Strong Buy with Decreased Target to $63 on, Feb 23rd, 2024
[ 12:00 AM ] - United States, WOPRAI
Maria Ripps Reiterated (W) at Strong Buy and Held Target at $80 on, Feb 23rd, 2024
[ 12:00 AM ] - United States, WOPRAI
Oliver Wintermantel Maintained (W) at Hold with Increased Target to $60 on, Feb 23rd, 2024
[ 12:00 AM ] - United States, WOPRAI
Steven Shemesh Maintained (W) at Hold with Increased Target to $62 on, Feb 23rd, 2024
[ 12:00 AM ] - United States, WOPRAI
Ygal Arounian Maintained (W) at Strong Buy with Decreased Target to $73 on, Feb 23rd, 2024
[ 12:00 AM ] - United States, WOPRAI
Peter Keith Reiterated (W) at Buy with Decreased Target to $88 on, Feb 23rd, 2024
[ 12:00 AM ] - United States, WOPRAI
Seth Basham Reiterated (W) at Buy and Held Target at $70 on, Feb 23rd, 2024
[ 12:00 AM ] - United States, WOPRAI
Christopher Raymond Maintained (BMRN) at Buy with Decreased Target to $107 on, Feb 23rd, 2024

Christopher Raymond Maintained (BMRN) at Buy with Decreased Target to $107 on, Feb 23rd, 2024


Published on 2024-10-28 09:11:32 - WOPRAI, Christopher Raymond
  Print publication without navigation


Christopher Raymond of Piper Sandler, Maintained "BioMarin Pharmaceutical Inc." (BMRN) at Buy with Decreased Target from $115 to $107 on, Feb 23rd, 2024.

Christopher has made no other calls on BMRN in the last 4 months.



There are 6 other peers that have a rating on BMRN. Out of the 6 peers that are also analyzing BMRN, 1 agrees with Christopher's Rating of Hold. Following is the relevant analyst calls for the last 4 months

  • William Pickering of "Bernstein" Upgraded from Sell to Hold and Held Target at $82 on, Monday, October 23rd, 2023


These are the ratings of the 5 analyists that currently disagree with Christopher

  • Joel Beatty of "Baird" Maintained at Buy with Decreased Target to $104 on, Tuesday, January 30th, 2024
  • Paul Matteis of "Stifel" Reiterated at Strong Buy and Held Target at $101 on, Thursday, December 21st, 2023
  • Kostas Biliouris of "BMO Capital" Maintained at Buy with Decreased Target to $100 on, Friday, November 3rd, 2023
  • Matthew Harrison of "Morgan Stanley" Maintained at Buy with Decreased Target to $117 on, Thursday, November 2nd, 2023
  • Gena Wang of "Barclays" Maintained at Buy with Decreased Target to $111 on, Thursday, November 2nd, 2023

Contributing Sources